A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7th issue of the journal Cancer Cell, may also drive creation of new strategies for the treatment of advanced prostate cancer that no longer responds to traditional anti-hormone therapies.
- A potential new target for treatment of hormone refractory prostate cancerMon, 6 Apr 2009, 12:22:28 EDT
- A new route for tackling treatment-resistant prostate cancerTue, 24 Jul 2012, 15:35:28 EDT
- Radiation added to hormone therapy increases survival for men with prostate cancerMon, 22 Sep 2008, 8:29:41 EDT
- Gene fusions may be the 'smoking gun' in prostate cancer development, U-M study findsTue, 18 May 2010, 14:39:15 EDT
- Age alone should not be used to determine whether to treat prostate cancer with hormonesWed, 24 Sep 2008, 11:31:03 EDT